Enrollment process for prescription drug plans
(1) Establishment of process
(1)Establishment of process#
(A) In general The Secretary shall establish a process for the enrollment, disenrollment, termination, and change of enrollment of part D eligible individuals in prescription drug plans consistent with this subsection.
(B) Application of MA rules In establishing such process, the Secretary shall use rules similar to (and coordinated with) the rules for enrollment, disenrollment, termination, and change of enrollment with an MA–PD plan under the following provisions of section 1395w–21 of this title : (i) Residence requirements Section 1395w–21(b)(1)(A) of this title , relating to residence requirements. (ii) Exercise of choice Section 1395w–21(c) of this title (other than paragraph (3)(A) and paragraph (4) of such section), relating to exercise of choice. (iii) Coverage election periods Subject to paragraphs (2) and (3) of this subsection, section 1395w–21(e) of this title (other than subparagraphs (B), (C), (E), and (F) of paragraph (2) and the second sentence of paragraph (4) of such section), relating to coverage election periods, including initial periods, annual coordinated election periods, special election periods, and election periods for exceptional circumstances. (iv) Coverage periods Section 1395w–21(f) of this title , relating to effectiveness of elections and changes of elections. (v) Guaranteed issue and renewal Section 1395w–21(g) of this title (other than paragraph (2) of such section and clause (i) and the second sentence of clause (ii) of paragraph (3)(C) of such section), relating to guaranteed issue and renewal. (vi) Marketing material and application forms Section 1395w–21(h) of this title , relating to approval of marketing material and application forms. In applying clauses (ii), (iv), and (v) of this subparagraph, any reference to section 1395w–21(e) of this title shall be treated as a reference to such section as applied pursuant to clause (iii) of this subparagraph.
(C) Special rule The process established under subparagraph (A) shall include, except as provided in subparagraph (D), in the case of a part D eligible individual who is a full-benefit dual eligible individual (as defined in section 1396u–5(c)(6) of this title ) who has failed to enroll in a prescription drug plan or an MA–PD plan, for the enrollment in a prescription drug plan that has a monthly beneficiary premium that does not exceed the premium assistance available under section 1395w–114(a)(1)(A) of this title ). 1 1 So in original. The closing parenthesis probably should not appear. If there is more than one such plan available, the Secretary shall enroll such an individual on a random basis among all such plans in the PDP region. Nothing in the previous sentence shall prevent such an individual from declining or changing such enrollment.
(D) Special rule for plans that waive de minimis premiums The process established under subparagraph (A) may include, in the case of a part D eligible individual who is a subsidy eligible individual (as defined in section 1395w–114(a)(3) of this title ) who has failed to enroll in a prescription drug plan or an MA–PD plan, for the enrollment in a prescription drug plan or MA–PD plan that has waived the monthly beneficiary premium for such subsidy eligible individual under section 1395w–114(a)(5) of this title . If there is more than one such plan available, the Secretary shall enroll such an individual under the preceding sentence on a random basis among all such plans in the PDP region. Nothing in the previous sentence shall prevent such an individual from declining or changing such enrollment.
(2)Initial enrollment period#
(A) Program initiation In the case of an individual who is a part D eligible individual as of November 15, 2005 , there shall be an initial enrollment period that shall be the same as the annual, coordinated open election period described in section 1395w–21(e)(3)(B)(iii) of this title , as applied under paragraph (1)(B)(iii).
(B) Continuing periods In the case of an individual who becomes a part D eligible individual after November 15, 2005 , there shall be an initial enrollment period which is the period under section 1395w–21(e)(1) of this title , as applied under paragraph (1)(B)(iii) of this section, 2 2 So in original. Probably should be “of this subsection,”. as if “entitled to benefits under part A or enrolled under part B” were substituted for “entitled to benefits under part A and enrolled under part B”, but in no case shall such period end before the period described in subparagraph (A).
(2)(A)Program initiation#
In the case of an individual who is a part D eligible individual as of November 15, 2005 , there shall be an initial enrollment period that shall be the same as the annual, coordinated open election period described in section 1395w–21(e)(3)(B)(iii) of this title , as applied under paragraph (1)(B)(iii).
(2)(B)Continuing periods#
In the case of an individual who becomes a part D eligible individual after November 15, 2005 , there shall be an initial enrollment period which is the period under section 1395w–21(e)(1) of this title , as applied under paragraph (1)(B)(iii) of this section, 2 2 So in original. Probably should be “of this subsection,”. as if “entitled to benefits under part A or enrolled under part B” were substituted for “entitled to benefits under part A and enrolled under part B”, but in no case shall such period end before the period described in subparagraph (A).
(3)Additional special enrollment periods#
The Secretary shall establish special enrollment periods, including the following:
(A) Involuntary loss of creditable prescription drug coverage (i) In general In the case of a part D eligible individual who involuntarily loses creditable prescription drug coverage (as defined in section 1395w–113(b)(4) of this title ). (ii) Notice In establishing special enrollment periods under clause (i), the Secretary shall take into account when the part D eligible individuals are provided notice of the loss of creditable prescription drug coverage. (iii) Failure to pay premium For purposes of clause (i), a loss of coverage shall be treated as voluntary if the coverage is terminated because of failure to pay a required beneficiary premium. (iv) Reduction in coverage For purposes of clause (i), a reduction in coverage so that the coverage no longer meets the requirements under section 1395w–113(b)(5) of this title (relating to actuarial equivalence) shall be treated as an involuntary loss of coverage.
(B) Errors in enrollment In the case described in section 1395p(h) of this title (relating to errors in enrollment), in the same manner as such section applies to part B.
(C) Exceptional circumstances In the case of part D eligible individuals who meet such exceptional conditions (in addition to those conditions applied under paragraph (1)(B)(iii)) as the Secretary may provide.
(D) Medicaid coverage In the case of an individual (as determined by the Secretary, subject to such limits as the Secretary may establish for individuals identified pursuant to section 1395w–104(c)(5) of this title ) who is a full-benefit dual eligible individual (as defined in section 1396u–5(c)(6) of this title ).
(E) Discontinuance of MA–PD election during first year of eligibility In the case of a part D eligible individual who discontinues enrollment in an MA–PD plan under the second sentence of section 1395w–21(e)(4) of this title at the time of the election of coverage under such sentence under the original medicare fee-for-service program.
(3)(A)Involuntary loss of creditable prescription drug coverage#
(4)Information to facilitate enrollment#
(A) In general Notwithstanding any other provision of law but subject to subparagraph (B), the Secretary may provide to each PDP sponsor and MA organization such identifying information about part D eligible individuals as the Secretary determines to be necessary to facilitate efficient marketing of prescription drug plans and MA–PD plans to such individuals and enrollment of such individuals in such plans.
(B) Limitation (i) Provision of information The Secretary may provide the information under subparagraph (A) only to the extent necessary to carry out such subparagraph. (ii) Use of information Such information provided by the Secretary to a PDP sponsor or an MA organization may be used by such sponsor or organization only to facilitate marketing of, and enrollment of part D eligible individuals in, prescription drug plans and MA–PD plans.
(4)(A)In general#
Notwithstanding any other provision of law but subject to subparagraph (B), the Secretary may provide to each PDP sponsor and MA organization such identifying information about part D eligible individuals as the Secretary determines to be necessary to facilitate efficient marketing of prescription drug plans and MA–PD plans to such individuals and enrollment of such individuals in such plans.
(4)(B)Limitation#
(i) Provision of information The Secretary may provide the information under subparagraph (A) only to the extent necessary to carry out such subparagraph.
(ii) Use of information Such information provided by the Secretary to a PDP sponsor or an MA organization may be used by such sponsor or organization only to facilitate marketing of, and enrollment of part D eligible individuals in, prescription drug plans and MA–PD plans.
(5)Reference to enrollment procedures for MA–PD plans#
For rules applicable to enrollment, disenrollment, termination, and change of enrollment of part D eligible individuals in MA–PD plans, see section 1395w–21 of this title .
(6)Reference to penalties for late enrollment#
Section 1395w–113(b) of this title imposes a late enrollment penalty for part D eligible individuals who—
(A) enroll in a prescription drug plan or an MA–PD plan after the initial enrollment period described in paragraph (2); and
(B) fail to maintain continuous creditable prescription drug coverage during the period of non-enrollment.
(6)(A)#
enroll in a prescription drug plan or an MA–PD plan after the initial enrollment period described in paragraph (2); and
(6)(B)#
fail to maintain continuous creditable prescription drug coverage during the period of non-enrollment.